New Jersey Recreational and Medical Marijuana Licensing Information
Adult Use
In New Jersey, adult use of marijuana was legalized following the November 2020 voter approval of Public Question 1, leading to the enactment of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act. This act was signed into law by Governor Phil Murphy on February 22, 2021. The regulatory body overseeing both recreational and medicinal marijuana in New Jersey is the Cannabis Regulatory Commission (CRC).
The following license types are currently available in New Jersey:
- Cultivator License – This license allows entities to legally grow cannabis. Applicants must detail their operational plans, including security and environmental impact measures, which vary depending on the scale of the operation. To prevent market saturation, the state limits the number of these licenses and enforces strict environmental compliance.
- Manufacturer License – This license is for businesses intending to create cannabis products. The application process is rigorous, requiring background checks and facility inspections to ensure compliance with health and safety standards. Fees are assessed both for the application and annually, covering the costs of regulatory oversight. Products must be appropriately labeled as per state guidelines.
- Dispensary License – Dispensaries must acquire this license to sell cannabis products directly to consumers. The application and annual fees vary by the size and location of the dispensary. These businesses must ensure that all customers are at least 21 years old and comply with local zoning laws that may limit where dispensaries can be located.
- Distributor License – Holders of this license are authorized to transport cannabis between facilities, such as from cultivation centers to dispensaries. The state requires distributors to adhere to regulations that ensure the secure transport and proper tracking of cannabis products.
- Delivery License – This license allows for the delivery of cannabis products directly to consumers at private residences. Applicants need to provide a comprehensive business plan and demonstrate robust security measures. Like other licenses, delivery services are regulated through fees intended to fund regulatory oversight and are limited to specific geographical and timing conditions.
Other Relevant Regulations
- Zoning Laws: Local municipalities have the authority to restrict or ban cannabis businesses within their jurisdictions.
- Consumer Safety: All cannabis products must undergo testing for potency and contaminants before being sold.
- Market Entry: New Jersey has provisions in place to encourage participation from small businesses and from communities disproportionately impacted by previous marijuana laws.
Hemp
The New Jersey Hemp Farming Act (the “Act”) was enacted in August 2019. The law legalized hemp production in New Jersey, permitting farmers and businesses to grow, handle, process, and sell hemp for commercial purposes, pursuant to an application process established by the New Jersey Department of Agriculture (NJDA). Previously, farmers and businesses were only legally permitted to cultivate hemp under New Jersey’s Industrial Hemp Pilot Program, which restricted hemp growth to academic or agricultural research. The New Jersey Hemp Farming Act repealed and replaced the aforementioned pilot program.
NJDA adopted rules governing the Act to license and promote the cultivation of industrial hemp. The rules established the New Jersey Hemp Program (the “Program”), which is administered by the Plants Division within NJDA. The objective of the Program is to provide licenses for growing, processing, and handling hemp pursuant to the Act, in addition to the 2018 Farm Bill and its implementing regulations. To be clear, to “handle” hemp does not mean to possess or store finished hemp products.
The Program established a schedule of fees to be paid based upon whether the hemp producer will be growing, processing, or handling hemp. Growers pay an annual $300 plus $15 per acre fee, handlers pay a $450 annual fee, and processors pay an annual fee for each type of hemp component they process. For example, a hemp producer who processes grain ($450) and CBD extract ($1,000) will pay an annual fee of $1,450. Growers are permitted to process and handle their own hemp without paying additional fees. However, once a grower processes or handles hemp from at least one separate hemp producer, the grower must pay applicable processor and handler fees. All prospective participants must complete an application, which has a background check component.
The sale of finished hemp products does not fall under the Program.
Psychedelics
In New Jersey, psychedelic substances are subject to several laws and regulations that reflect the evolving understanding of their potential therapeutic uses:
- State Scheduling of Psychedelics – Psychedelics such as psilocybin are still considered controlled substances under both federal and New Jersey state law. The possession, use, and distribution of these substances are regulated under these laws, except where specific exemptions have been made.
- Ketamine Laws and Telehealth – While primarily regulated as a controlled substance, ketamine can be prescribed for certain medical conditions. New Jersey allows telehealth services, which include the remote prescription of medicines, though controlled substances are generally subject to stricter regulations to prevent misuse.
- State Right to Try – New Jersey adheres to the “Right to Try” laws, which allow terminally ill patients to try experimental treatments, including potentially some psychedelic substances, as part of their care regimen. These laws are intended to give patients access to treatments that have not yet completed the full FDA approval process.
- State Religious Exemptions – While federal rulings have recognized certain religious exemptions for the use of psychedelics (e.g., ayahuasca in specific religious ceremonies), New Jersey’s specific stance on religious exemptions for psychedelic use is less clear and would generally fall under broader federal guidelines.
- Legislative Changes – Senate Bill S3256, passed on February 4, 2021, amended state law to reduce penalties associated with the possession of one ounce or less of psilocybin to a disorderly persons offense, significantly decreasing the previous penalties. Following this, more expansive measures have been proposed, such as the “Psilocybin Behavioral Health Access and Services Act” (S2934 and its successor, S2283/A3852). This legislation aims to decriminalize the production, possession, and use of psilocybin for adults over the age of 21 and establish a regulated framework for its therapeutic use.
These legislative efforts illustrate a significant shift toward considering the medical and therapeutic potential of psychedelics, reflecting a broader trend seen in various U.S. states. The discussion around psychedelics in New Jersey continues to evolve, with ongoing debates and proposals aimed at integrating these substances safely and effectively into healthcare and therapy contexts.
Check Other States Licensing Guide
- Adult Use
- Medical
- Limited Medical
- Illegal
Where to Find Us
Address
Contact INFO
PHONE: 786-526-1155
EMAIL: info@mrcannabislaw.com
